We recently published a list of Jim Cramer Recently Talked About These 12 Companies. In this article, we are going to take a ...

ResMed (NYSE:RMD – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” ...

A big reason for Resmed’s recently announced rebrand is to reflect its increased direct-to-consumer engagement on obstructive sleep apnea and CPAP therapy. Chief Marketing Officer Katrin ...

Independent Advisor Alliance acquired a new stake in shares of ResMed Inc. (NYSE:RMD – Free Report) during the fourth quarter ...

Shares of ResMed Inc. RMD shed 4.58% to $225.79 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.76% to 5,572.07 and Dow ...

Shares of ResMed Inc. RMD rose 2.02% to $224.16 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 2.13% to 5,638.94 and the ...

Let’s take a look at how ResMed (NYSE:RMD) and the rest of the patient monitoring stocks fared in Q4. Patient monitoring companies within the healthcare equipment industry offer devices and ...